The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.

It's been a long time coming: Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the Seattle biotech has finally scored its ...

A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. The Christmas Eve regulatory ...

MELVILLE, N.Y., June 13, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX” or the “Company”) (NASDAQ: BRTX), a clinical ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous stem cell company treating those who suffer in pain from peripheral arterial disease, chronic limb threatening ischemia, ...

But the family is convinced of their next step -- taking Sierra on an arduous trip to southern China, where they believe the little girl will be injected six times with stem cells during a 34-day stay ...

The U.S. Food and Drug Administration today posted a warning letter issued to US Stem Cell Clinic of Sunrise, Florida, and its Chief Scientific Officer Kristin Comella for marketing stem cell products ...

SAN FRANCISCO (KGO) -- How the FCC and wireless carriers are preparing for Hurricane Dorian -- and how consumers should prep their own phones The Federal Communications Commission is working with ...

Mesoblast (ASX:MSB) has seen its shares dip on Monday morning out the gate as some investors struggle to digest what exactly ...

Hemostemix receives US FDA support for its basket protocol approach: Calgary, Alberta Tuesday, January 20, 2026, 18:00 Hrs [IST] Hemostemix Inc., the leading autologous stem cell ...